← TrialMatch
HomeTrials

A Study on the Preference of Risperidone Dosage Forms

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

Condition(s)Schizophrenia, Bipolar Affective Disorder, Autism Spectrum Disorder, Conduct Disorder, Mental Retardation
StatusRecruiting
Study typeObservational
SummaryThis study aimed to understand patients' needs and preferences for antipsychotic dosage forms.
Who can participateInclusion Criteria: * Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study. Exclusion Criteria: * Have difficulty reading and understanding Chinese or refuse to participate in the study.
Ages18 Years
SexAll
Lead sponsorShanghai Mental Health Center
LocationsShanghai, Shanghai Municipality, China
Start date2024-09-19
NCT IDNCT06657430
Official listinghttps://clinicaltrials.gov/study/NCT06657430

🔍 Search all trials →